ストックスクリーナーアプリを入手
14.69
2.07%
0.3276
前日終値:
$14.36
開ける：
$14.5
24時間の取引高:
161.36K
Relative Volume:
0.08
時価総額：
$1.74B
収益：
$631.73M
当期純損益:
$-239.78M
株価収益率:
-7.6898
EPS:
-1.91
ネットキャッシュフロー:
$-33.45M
1週間 パフォーマンス:
-0.09%
1か月 パフォーマンス:
-11.01%
6か月 パフォーマンス:
-22.33%
1年 パフォーマンス:
-73.01%
1日の値動き範囲:
$14.50
$14.84
1週間の範囲:
$13.92
$14.84
52週間の値動き範囲:
$12.95
$54.73
10 X Genomics Inc Stock (TXG) Company Profile
名前
10 X Genomics Inc
セクター
電話
(925) 401-7300
住所
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
TXG を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TXG
10 X Genomics Inc
|
14.64 | 1.74B | 631.73M | -239.78M | -33.45M | -2.02 |
|
VEEV
Veeva Systems Inc
|
213.23 | 34.13B | 2.66B | 665.91M | 1.08B | 4.05 |
|
SOLV
Solventum Corp
|
66.15 | 11.41B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
53.72 | 9.97B | 516.85M | 174.11M | 217.38M | 0.87 |
|
HQY
Healthequity Inc
|
97.00 | 8.32B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
36.80 | 6.32B | 906.14M | -52.62M | 89.62M | -0.3621 |
10 X Genomics Inc Stock (TXG) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-09-03 | 開始されました | Leerink Partners | Outperform |
| 2024-07-22 | アップグレード | Jefferies | Hold → Buy |
| 2024-07-18 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-07-10 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2024-06-27 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2024-06-25 | ダウングレード | Guggenheim | Buy → Neutral |
| 2024-06-03 | 再開されました | Jefferies | Hold |
| 2024-05-01 | ダウングレード | TD Cowen | Buy → Hold |
| 2023-12-14 | 開始されました | Guggenheim | Buy |
| 2023-12-13 | 開始されました | Wolfe Research | Outperform |
| 2023-12-12 | アップグレード | BofA Securities | Underperform → Neutral |
| 2023-07-05 | 再開されました | JP Morgan | Overweight |
| 2023-05-10 | 開始されました | Barclays | Overweight |
| 2023-03-31 | 開始されました | Stephens | Overweight |
| 2023-02-02 | 開始されました | UBS | Neutral |
| 2022-12-14 | 開始されました | Deutsche Bank | Buy |
| 2022-08-18 | ダウングレード | Goldman | Neutral → Sell |
| 2022-07-25 | 開始されました | Canaccord Genuity | Buy |
| 2022-07-15 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2022-07-15 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-09-14 | ダウングレード | BofA Securities | Buy → Neutral |
| 2021-03-15 | 開始されました | William Blair | Outperform |
| 2020-12-02 | 開始されました | Goldman | Neutral |
| 2020-09-09 | 開始されました | Morgan Stanley | Overweight |
| 2020-07-10 | 開始されました | Stifel | Buy |
| 2020-03-05 | 開始されました | Guggenheim | Buy |
| 2020-01-07 | 開始されました | Citigroup | Buy |
| 2019-10-07 | 開始されました | BofA/Merrill | Buy |
| 2019-10-07 | 開始されました | Cowen | Outperform |
| 2019-10-07 | 開始されました | JP Morgan | Overweight |
| 2019-09-24 | 開始されました | Evercore ISI | Outperform |
すべてを表示
10 X Genomics Inc (TXG) 最新ニュース
10x Genomics, Inc. (NASDAQ:TXG) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Cathie Wood's ARK ETF adjusts, adds 10X Genomics, sells Rocket Lab - Investing.com
Geode Capital Management LLC Boosts Stock Position in 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat
10x Genomics wins permanent injunction against NanoString - MSN
10x Genomics secures injunction against Bruker By Investing.com - Investing.com Australia
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought - The Motley Fool
U.S. District Court Awards 10x Genomics Permanent Injunction in Patent Infringement Lawsuit Against Bruker Corporation's GeoMx Products - The Malaysian Reserve
U.S. District Court Awards 10x Genomics Permanent Injunction in - GuruFocus.com
10x Genomics secures injunction against Bruker - Investing.com India
U.S. District Court Awards 10x Genomics Permanent Injunction in Patent Infringement Lawsuit Against Bruker Corporation's GeoMx Products – Company AnnouncementFT.com - Financial Times
U.S. District Court Awards 10x Genomics Permanent Injunction in Patent Infringement Lawsuit Against Bruker Corporation's GeoMx Products (PR Newswire) - Aktiellt
10x Genomics (NASDAQ:TXG) Trading Up 4.3%Should You Buy? - MarketBeat
State Street Corp Increases Stock Position in 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat
Goldman Sachs Maintains 10x Genomics Inc(TXG) Sell Recommendation - MSN
10X Genomics' SWOT analysis: genomics firm navigates challenges, eyes recovery - Investing.com
Insider Sellers Might Regret Selling 10x Genomics Shares at a Lower Price Than Current Market Value - Simply Wall St
Barclays PLC Has $13.61 Million Stake in 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat
10X Genomics' SWOT analysis: genomics firm's stock faces instrument demand headwinds - Investing.com
10x Genomics Announces Mega-Scale Single Cell Analysis for One Cent Per Cell at Human Cell Atlas General Meeting - The Eastern Progress Online
XTX Topco Ltd Purchases 31,844 Shares of 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat
10x Genomics Reports Third Quarter 2024 Financial Results - The Eastern Progress Online
46,029 Shares in 10x Genomics, Inc. (NASDAQ:TXG) Purchased by Weiss Asset Management LP - MarketBeat
Quantinno Capital Management LP Raises Stake in 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat
Charles Schwab Investment Management Inc. Has $14.71 Million Stock Holdings in 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat
10x Genomics (FRA:1KJ) Current Ratio : 4.90 (As of Sep. 2024) - GuruFocus.com
TechBio Startup Cure51 Selects 10x Genomics Visium HD for New Drug Discovery Initiative - The Eastern Progress Online
Point72 Asset Management L.P. Invests $27.78 Million in 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat
Benjamin Edwards Inc. Buys 57,948 Shares of 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat
Brokerages Set 10x Genomics, Inc. (NASDAQ:TXG) PT at $29.19 - MarketBeat
10x Genomics Inc (TXG) Stock Price Down 3.81% on Dec 5 - GuruFocus.com
10x Genomics (FRA:1KJ) EV-to-EBIT : -9.57 (As of Dec. 05, 2024) - GuruFocus.com
10x Genomics (STU:1KJ) Shares Outstanding (EOP) : 121.0 Mil (As of Sep. 2024) - GuruFocus.com
10x Genomics (FRA:1KJ) Interest Coverage : 0 (At Loss) (As of Sep. 2024) - GuruFocus.com
10x Genomics (FRA:1KJ) Shareholder Yield % : 0.42% (As of Sep. 2024) - GuruFocus.com
10x Genomics (FRA:1KJ) EV-to-FCF : 68.14 (As of Dec. 05, 2024) - GuruFocus.com
10x Genomics (STU:1KJ) Price-to-Operating-Cash-Flow : 50.18 (As of Dec. 05, 2024) - GuruFocus.com
10x Genomics (FRA:1KJ) 3-Year Revenue Growth Rate : 21.40% (As of Sep. 2024) - GuruFocus.com
10x Genomics (MEX:TXG) Shares Outstanding (EOP) : 121 Mil (As of Sep. 2024) - GuruFocus.com
Cinctive Capital Management LP Takes $3.67 Million Position in 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat
10x Genomics Inc (TXG) Shares Up 2.74% on Dec 2 - GuruFocus.com
Fmr LLC Has $301.85 Million Position in 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat
TXG (10x Genomics) Enterprise Value : $1,561.6 Mil (As of Nov. 30, 2024) - GuruFocus.com
10x genomics chief scientific officer sells $79,485 in stock - Investing.com India
10x genomics chief scientific officer sells $79,485 in stock By Investing.com - Investing.com Australia
TXG (10x Genomics) 6-1 Month Momentum % : -31.43% (As of Nov. 26, 2024) - GuruFocus.com
TXG (10x Genomics) Effect of Exchange Rate Changes : $0.2 Mil (TTM As of Sep. 2024) - GuruFocus.com
10x genomics CEO Serge Saxonov sells $91,612 in stock By Investing.com - Investing.com Australia
10x genomics CEO Serge Saxonov sells $91,612 in stock - Investing.com India
10x Genomics (LTS:0A88) Operating Cash Flow per Share : $0.33 (TTM As of Sep. 2024) - GuruFocus.com
10 X Genomics Inc (TXG) 財務データ
収益
当期純利益
現金流量
EPS
10 X Genomics Inc (TXG) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Saxonov Serge | Chief Executive Officer |
Nov 22 '24 |
Sale |
13.69 |
6,693 |
91,612 |
872,574 |
| Hindson Benjamin J. | See Remarks |
Nov 22 '24 |
Sale |
13.69 |
5,807 |
79,485 |
339,897 |
0.31%
0.18%
大文字化:
|
ボリューム (24 時間):